Foundation Medicine Announces 2018 First Quarter Results and Recent Highlights
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Foundation Medicine (FMI) Tops Q1 EPS by 8c
May 2, 2018 4:47 PM EDTFoundation Medicine (NASDAQ: FMI) reported Q1 EPS of ($1.02), $0.08 better than the analyst estimate of ($1.10). Revenue for the quarter came in at $52.8 million versus the consensus estimate of $44.92 million.
GUIDANCE:
Foundation Medicine sees FY2018 revenue of $200-220 million, versus the consensus of... More
